Skip to content
Screener

Cardiff Oncology CRDF Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$120.0KBeat by $16.5K
EPS-$0.17Beat by $0.03
Revenue estimate$103.5K
EPS estimate-$0.20

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.2K
EPS estimate-$0.15

FAQ

When did Cardiff Oncology report Q3 2025 earnings?
Cardiff Oncology (CRDF) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Cardiff Oncology's Q3 2025 revenue and EPS?
Cardiff Oncology reported revenue of $120.0K and eps of $-0.17 for Q3 2025.
Did Cardiff Oncology beat estimates in Q3 2025?
Revenue beat the consensus estimate of $103.5K by $16.5K. EPS beat the consensus estimate of $-0.20 by $0.03.
How did Cardiff Oncology's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.3% from $165.0K a year earlier and eps grew 32.0% from $-0.25.
Where can I find Cardiff Oncology's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269492) and the 10-Q periodic report (0001193125-25-269424) directly on SEC EDGAR. The filing index links above go to sec.gov.